… We noted evidence for Cushing’s syndrome in 3 pediatric patients after intra-articular or
intradermal administration of TCA. One of them had received a therapeutic dose of TCA. The …

… Cushing syndrome (CS), first described by Harvey Cushing in 1910, is … syndrome is
exogenous administration of glucocorticoids (GCs) for therapeutic purpose.[ 1 ] The term “Cushing's …

… Newell-Price J, Trainer P, Besser GM, Grossman AB, 1998 The diagnosis and differential
diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 19: 647-672. …

… The diagnosis of ACTH-dependent Cushing's syndrome (CS) was made when the
plasma ACTH was >10 pg/mL (2.2 pmol/L). In these patients, a high-dose dexamethasone …

… Cushing syndrome is caused by prolonged exposure to high circulating levels of cortisol.
The most common cause of cushingoid features is iatrogenic corticosteroid use, while some …

… In this Review, we focus on the advances in the medical therapy for Cushing's syndrome …
Corticotroph adenomas express multiple G-protein coupled receptors (GPCRs), including …

… in our study compared with earlier studies by Singh et al, Srivastav et al and Venkateshwarlu
Nandyala et al in the … Pivonello R, Faggiano A, Lombardi G, Colao A. The metabolic …

… Prolonged glucocorticoid overexposure leads to Cushing’s syndrome (CS). It is … She exhibited
several features specific to CS and was subsequently diagnosed with Cushing’s disease. …

… We extracted data on subfoveal choroidal thickness in patients with Cushing’s syndrome …
patients with Cushing’s syndrome. On average, patients with Cushing’s syndrome have 49.5 …

… Cushing's syndrome (CS) is a chronic and systemic disease caused by endogenous or …
Dal Bo Zanon R, Fornasiero L, Boscaro M, Cappellato G, Fabris F, Girolami A. Increased …